Science Continues To Outpace Commercialization Of Cell And Gene Therapies
The continued lack of robust revenue for approved cell and gene therapies is a reminder that being innovative doesn ’t necessarily translate into profitability.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Joshua Cohen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news